Generic Application Mystery: Few ANDAs Withdrawn To Start FY 2023

 
• By Derrick Gingery
  
generic drugs
US FDA maintained its average ANDA approval pace during the first two months of FY 2023 as was seen in FY 2022. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from Biosimilars & Generics